3,3'-Diindolylmethane increases bone mass by suppressing osteoclastic bone resorption in mice

Area of Science:

• Biochemistry
• Bone Metabolism
• Pharmacology

Background:

• 3,3 '-Diindolylmethane (DIM), a cruciferous vegetable metabolite, exhibits anticancer and anti-inflammatory properties.
• Its role in bone metabolism remains largely unexplored.
• Understanding DIM's skeletal effects is crucial for potential therapeutic applications.

Purpose of the Study:

• To investigate the impact of DIM on bone mass.
• To determine DIM's effects under physiological and pathological conditions.
• To elucidate the mechanisms underlying DIM's influence on bone metabolism.

Main Methods:

• Administration of DIM to healthy female mice and an ovariectomized (OVX) osteoporotic mouse model.
• Assessment of bone mass using dual-energy X-ray absorptiometry (DEXA) and micro-computed tomography (μCT).
• Bone histomorphometric analyses to evaluate bone formation and resorption parameters.

Main Results:

• DIM treatment significantly increased bone mass in healthy mice.
• DIM administration prevented ovariectomized (OVX)-induced bone loss.
• DIM suppressed osteoclast-mediated bone resorption without affecting bone formation.

Conclusions:

• DIM enhances bone mass by inhibiting osteoclastic bone resorption.
• DIM demonstrates potential for treating and preventing bone loss diseases, including postmenopausal osteoporosis.